Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 28  •  01:55PM ET
25.70
Dollar change
+0.22
Percentage change
0.88
%
May 26, 8:05 AMProgyny announces Board-approved share repurchase program authorizing up to $200 million of its common stock funded from available cash balances.
Index
RUT
P/E
33.38
EPS (ttm)
0.77
Insider Own
11.10%
Shs Outstand
78.27M
Perf Week
0.25%
Market Cap
2.01B
Forward P/E
17.33
EPS next Y
1.48
Insider Trans
-0.33%
Shs Float
69.58M
Perf Month
39.85%
Enterprise Value
1.81B
PEG
0.48
EPS next Q
0.33
Inst Own
103.68%
Perf Quarter
15.52%
Income
67.69M
P/S
1.56
EPS this Y
96.77%
Inst Trans
-0.00%
Perf Half Y
-2.38%
Sales
1.29B
P/B
4.58
EPS next Y
15.95%
ROA
9.48%
Perf YTD
0.09%
Book/sh
5.61
P/C
8.90
EPS next 5Y
36.07%
ROE
14.93%
52W High
28.75 -10.60%
Perf Year
20.96%
Cash/sh
2.89
P/FCF
10.92
EPS past 3/5Y
28.95% 6.78%
ROIC
14.63%
52W Low
16.10 59.65%
Perf 3Y
-31.26%
Dividend Est.
-
EV/EBITDA
17.82
Sales past 3/5Y
17.87% 30.17%
Gross Margin
24.11%
Volatility
4.70% 4.44%
Perf 5Y
-59.86%
Dividend TTM
-
EV/Sales
1.40
EPS Y/Y TTM
36.67%
Oper. Margin
7.46%
ATR (14)
1.00
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
2.13
Sales Y/Y TTM
6.59%
Profit Margin
5.23%
RSI (14)
73.86
Dividend Gr. 3/5Y
- -
Current Ratio
2.13
EPS Q/Q
69.57%
SMA20
13.64%
Beta
1.01
Payout
0.00%
Debt/Eq
0.06
Sales Q/Q
1.38%
SMA50
31.16%
Rel Volume
0.42
Prev Close
25.48
Employees
856
LT Debt/Eq
0.05
SMA200
17.56%
Avg Volume
1.58M
Price
25.70
IPO
Oct 25, 2019
Option/Short
Yes / Yes
Trades
Volume
464,070
Change
0.88%
Date Action Analyst Rating Change Price Target Change
May-19-26Upgrade Canaccord Genuity Hold → Buy $30
Jan-20-26Upgrade Citizens JMP Mkt Perform → Mkt Outperform $30
Jan-08-26Upgrade Truist Hold → Buy $34
Dec-09-25Initiated Barclays Overweight $29
Nov-12-25Upgrade KeyBanc Capital Markets Sector Weight → Overweight $30
Jul-08-25Upgrade Leerink Partners Market Perform → Outperform $28
Dec-02-24Downgrade JP Morgan Overweight → Neutral $17
Nov-13-24Downgrade Truist Buy → Hold $26 → $19
Sep-19-24Downgrade JMP Securities Mkt Outperform → Mkt Perform
Aug-07-24Downgrade Leerink Partners Outperform → Market Perform $31 → $25
Today 09:04AM
May-26-26 08:00AM
May-19-26 09:34AM
May-11-26 10:57AM
May-08-26 10:58AM
08:54PM Loading…
May-07-26 08:54PM
05:06PM
04:01PM
May-06-26 09:25AM
Apr-23-26 01:55PM
Apr-16-26 09:05AM
Apr-01-26 09:23AM
Mar-06-26 09:02AM
Feb-27-26 12:35PM
04:30AM
12:03AM Loading…
12:03AM
Feb-26-26 06:45PM
06:30PM
05:20PM
04:12PM
04:01PM
Feb-25-26 09:15AM
07:28AM
Feb-24-26 10:07PM
Feb-12-26 02:46PM
Jan-22-26 07:20AM
03:23AM
Jan-20-26 03:10PM
Jan-14-26 11:35PM
Jan-12-26 10:07AM
08:00AM Loading…
08:00AM
Jan-09-26 09:15AM
09:04AM
Jan-08-26 11:36AM
Dec-31-25 11:04PM
Dec-23-25 09:15AM
Dec-22-25 09:15AM
Dec-16-25 11:32PM
Dec-15-25 12:00PM
Dec-08-25 11:31PM
Dec-07-25 11:39PM
Nov-25-25 09:15AM
Nov-24-25 12:45PM
Nov-20-25 09:23AM
Nov-18-25 09:15AM
Nov-17-25 10:37PM
Nov-14-25 11:40AM
Nov-13-25 12:33PM
12:37AM
Nov-12-25 11:35PM
09:45AM
Nov-07-25 01:02PM
09:21AM
12:08AM
Nov-06-25 05:20PM
04:13PM
04:08PM
04:01PM
Nov-05-25 07:36AM
Nov-04-25 10:09PM
Oct-27-25 03:13AM
Oct-23-25 01:08PM
09:40AM
Oct-22-25 04:55PM
09:28AM
Oct-07-25 09:40AM
09:30AM
Oct-02-25 12:04AM
Sep-26-25 08:05AM
Sep-15-25 11:32PM
Sep-05-25 02:36PM
Sep-01-25 12:20PM
09:15AM
Aug-27-25 12:32PM
Aug-21-25 12:33AM
Aug-18-25 02:40PM
Aug-14-25 01:35AM
Aug-12-25 09:00AM
03:07AM
Aug-08-25 03:38AM
Aug-07-25 06:20PM
05:30PM
04:48PM
04:02PM
Aug-05-25 11:16PM
Aug-04-25 06:15PM
Aug-01-25 07:15AM
Jul-31-25 10:00AM
Jul-30-25 09:19AM
Jul-24-25 12:10PM
Jul-21-25 01:15PM
Jul-18-25 12:25PM
Jul-10-25 09:06AM
09:06AM
Jul-09-25 07:35AM
Jul-08-25 08:09AM
Jun-30-25 08:55AM
Jun-26-25 12:33AM
Jun-24-25 02:07PM
10:42AM
Progyny, Inc. is a fertility benefits management company. It provides fertility solutions to employers, managing IUI, in vitro fertilization (IVF), egg freezing, and other fertility treatments. It operates through one segment: fertility and pharmacy benefits solutions. It also delivers treatment services and access to the firm's network of fertility specialist. The company was founded on April 3, 2008 and is headquartered in New York, NY.
Executive ChairmanMr. David J. Schlanger J.D.
CEO & DirectorMr. Peter Anevski CPA
Chief Financial OfficerMr. Mark S. Livingston CPA
Chief Operating OfficerMs. Melissa B. Cummings
Executive VPMs. Allison Swartz
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Swartz AllisonOfficerMay 28 '26Proposed Sale25.462,39861,053May 28 10:17 AM
GORDON KEVIN KDirectorMay 27 '26Proposed Sale24.995,500137,445May 27 11:25 AM
Scott CherylDirectorMay 22 '26Proposed Sale24.732,67666,177May 22 12:15 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERMay 20 '26Sale25.508,275211,01279,063May 21 04:23 PM
Cummings Melissa BChief Operating OfficerMay 19 '26Sale25.009,578239,45073,371May 21 04:22 PM
Livingston Mark S.OfficerMay 20 '26Proposed Sale25.508,275211,012May 20 03:07 PM
Cummings Melissa BOfficerMay 19 '26Proposed Sale25.009,578239,450May 19 11:52 AM
Swartz AllisonEVP, GCMar 04 '26Sale17.5459910,50688,941Mar 06 04:36 PM
Swartz AllisonEVP, GCMar 03 '26Sale17.404,65781,03089,879Mar 04 05:31 PM
Swartz AllisonEVP, GCMar 02 '26Sale17.272,19937,97797,378Mar 04 05:31 PM
Swartz AllisonOfficerMar 04 '26Proposed Sale17.5459910,506Mar 04 12:00 PM
Swartz AllisonOfficerMar 03 '26Proposed Sale17.404,65781,030Mar 03 02:59 PM
Swartz AllisonOfficerMar 02 '26Proposed Sale17.272,19937,977Mar 02 02:54 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERDec 11 '25Sale25.5045911,70446,983Dec 15 04:12 PM
Livingston Mark S.OfficerDec 11 '25Proposed Sale25.5045911,704Dec 11 02:55 PM
Swartz AllisonEVP, GCDec 04 '25Sale24.5953013,03372,719Dec 08 04:23 PM
Livingston Mark S.CHIEF FINANCIAL OFFICERDec 02 '25Sale25.502135,43247,921Dec 04 04:17 PM
Swartz AllisonOfficerDec 04 '25Proposed Sale24.5953013,033Dec 04 09:41 AM
Swartz AllisonEVP, GCNov 28 '25Sale26.872,39864,43473,657Dec 02 04:15 PM
Livingston Mark S.OfficerDec 02 '25Proposed Sale25.502135,432Dec 02 10:24 AM
Swartz AllisonOfficerNov 28 '25Proposed Sale26.872,39864,434Nov 28 09:39 AM
Livingston Mark S.CHIEF FINANCIAL OFFICERNov 17 '25Sale25.5021,303543,22648,358Nov 19 05:03 PM
Payson NormanDirectorNov 14 '25Option Exercise1.4536,22452,52556,954Nov 18 04:48 PM
Livingston Mark S.OfficerNov 17 '25Proposed Sale25.5021,303543,226Nov 17 12:31 PM
Anevski PeterCHIEF EXECUTIVE OFFICERNov 13 '25Buy24.2979,5001,930,896680,251Nov 17 08:22 AM
Swartz AllisonEVP, GCSep 04 '25Sale23.5359914,09477,407Sep 05 04:39 PM
Swartz AllisonOfficerSep 04 '25Proposed Sale23.5359914,094Sep 04 09:35 AM
Swartz AllisonEVP, GCAug 28 '25Sale22.962,39855,05879,697Sep 02 05:04 PM
Swartz AllisonOfficerAug 28 '25Proposed Sale22.962,39855,058Aug 28 11:28 AM
GORDON KEVIN KDirectorAug 11 '25Sale22.042,50055,08812,501Aug 13 06:12 PM
GORDON KEVIN KDirectorAug 11 '25Proposed Sale22.042,50055,088Aug 11 01:58 PM
Scott CherylDirectorJun 11 '25Sale22.072,67559,03714,112Jun 12 05:07 PM
Scott CherylDirectorJun 11 '25Proposed Sale22.072,67559,039Jun 11 12:44 PM
Cohen Fred EFormer DirectorJun 03 '25Proposed Sale21.6862,2441,349,450Jun 03 12:05 PM